What is the share price of Health X Platform Ltd (HEALTHX) today?
The share price of HEALTHX as on 6th August 2026 is ₹308.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Health X Platform Ltd (HEALTHX) share?
The past returns of Health X Platform Ltd (HEALTHX) share are- Past 1 week: -2.11%
- Past 1 month: -0.95%
- Past 3 months: 8.67%
- Past 6 months: 3.57%
- Past 1 year: 14.53%
- Past 3 years: 18.22%
- Past 5 years: -1.83%
What are the peers or stocks similar to Health X Platform Ltd (HEALTHX)?
The peers or stocks similar to Health X Platform Ltd (HEALTHX) include:What is the market cap of Health X Platform Ltd (HEALTHX) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Health X Platform Ltd (HEALTHX) is ₹974.04 Cr as of 6th August 2026.What is the 52 week high and low of Health X Platform Ltd (HEALTHX) share?
The 52-week high of Health X Platform Ltd (HEALTHX) is ₹363 and the 52-week low is ₹252.50.What is the PE and PB ratio of Health X Platform Ltd (HEALTHX) stock?
The P/E (price-to-earnings) ratio of Health X Platform Ltd (HEALTHX) is 825.46. The P/B (price-to-book) ratio is 1.13.Which sector does Health X Platform Ltd (HEALTHX) belong to?
Health X Platform Ltd (HEALTHX) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Health X Platform Ltd (HEALTHX) shares?
You can directly buy Health X Platform Ltd (HEALTHX) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Health X Platform Ltd
HEALTHX Share Price
NSE₹308.900.03% (-0.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
HEALTHX Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
HEALTHX Performance & Key Metrics
HEALTHX Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 846.99 | 1.13 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.38 | 5.86 | 0.51% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
HEALTHX Company Profile
Health X Platform Limited operates digital healthcare networks offering pharmacy, diagnostics, wellness products, pathology, radiology, and financial services including loans, wealth management, and financial consultancy in India.
PE Ratio
43.66
43.66
1Y Return
10.11%
10.11%
Buy Reco %
87.50
87.50
POLYMED
PE Ratio
53.76
53.76
1Y Return
12.67%
12.67%
Buy Reco %
75.00
75.00
FISCHER
PE Ratio
79.46
79.46
1Y Return
61.10%
61.10%
Buy Reco %
0.00
0.00
TARSONS
PE Ratio
121.89
121.89
1Y Return
12.03%
12.03%
Buy Reco %
100.00
100.00
BOROSCI
PE Ratio
36.17
36.17
1Y Return
12.33%
12.33%
Buy Reco %
0.00
0.00
HEALTHX Sentiment Analysis
HEALTHX Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
HEALTHX Stock Summary · June 2026
Management framed the quarter as solid progress on scale and margin recovery while investing for growth, with FY26 revenue of Rs. 1,283 crore and a longer‑term FY2030 revenue ambition of Rs. 6,000 crore. They highlighted improved gross margins and sharply narrowed losses, described the HealthX repositioning as a capital‑efficient, technology‑led healthcare platform spanning distribution, digital, diagnostics and preventive care, and emphasized priorities of AI‑driven efficiency, affordability, product genuineness and trust. Management pointed to rapid Retailer Shakti expansion and an early, modest private‑label launch as proof of commercial traction, but repeatedly cautioned that technology investments, fulfillment build‑out and category expansion are creating near‑term cost pressure that keeps profitability muted. Operationally they are expanding AI‑led fulfillment capacity and will fund capex from a mix of bank loans and internal treasury, while introducing separate disclosure of contribution margin and tech costs next quarter. Near term they expect ROE and profits to remain muted in FY27–FY28 with a sharp improvement by FY29–FY30 as scale and operating leverage materialize.
HEALTHX Stock Growth Drivers
HEALTHX Stock Growth Drivers
8Platform Repositioning into an Integrated, Capital‑Efficient Healthcare Ecosystem
The company completed a strategic rebrand to the HealthX identity and repositioned from a healthcare-commerce
Rapid Scale and Market Reach of Retailer Shakti
Retailer Shakti has become a large, fast-growing B2B pharmacy supply platform, reporting nearly 78% CAGR
HEALTHX Stock Challenges
HEALTHX Stock Challenges
6Near-term profitability weakness and reliance on non-operating income
Reported PAT swung to a loss of Rs.12.9 crore in the quarter versus a profit
Capital‑intensive expansion with execution and timeline risk
The company has articulated an aggressive scale-up plan that it says is necessary to reach
HEALTHX Forecast
HEALTHX Forecasts
Price
Revenue
Earnings
HEALTHX Share Price Forecast
HEALTHX Share Price Forecast
2026
Current
₹308.90
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹308.90
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HEALTHX Company Revenue Forecast
HEALTHX Company Revenue Forecast
2026
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
HEALTHX Stock EPS (Earnings Per Share) Forecast
HEALTHX Stock EPS (Earnings Per Share) Forecast
2026
Current
₹0.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹0.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HEALTHX
HEALTHX
Income
Balance Sheet
Cash Flow
Quarterly Normal View
HEALTHX Income Statement
HEALTHX Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 394.63 | 325.13 | 299.04 | 295.82 | 269.46 | 307.75 | 323.81 | 306.83 | 359.35 | 387.54 | ||||||||||
Operating & Other expenses | 371.30 | 317.59 | 272.80 | 468.01 | 307.26 | 311.03 | 292.46 | 324.15 | 356.27 | 400.43 | ||||||||||
EBITDA | 23.33 | 7.54 | 26.24 | -172.19 | -37.80 | -3.28 | 31.35 | -17.32 | 3.08 | -12.89 | ||||||||||
| Depreciation/Amortization | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 | 1.94 | ||||||||||
| PBIT | 21.02 | 5.01 | 24.63 | -173.64 | -39.23 | -4.62 | 30.18 | -18.65 | 0.91 | -14.83 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | 21.02 | 5.01 | 24.63 | -173.64 | -39.23 | -4.62 | 30.18 | -18.65 | 0.91 | -14.83 | ||||||||||
| Taxes & Other Items | 21.75 | -11.41 | -6.52 | -64.21 | -12.31 | -18.30 | 6.27 | -5.95 | -0.21 | -3.65 | ||||||||||
| Net Income | -0.73 | 16.42 | 31.15 | -109.43 | -26.92 | 13.68 | 23.91 | -12.70 | 1.12 | -11.18 | ||||||||||
| EPS | -0.23 | 5.17 | 9.79 | -34.40 | -8.47 | 4.30 | 7.52 | -3.99 | 0.35 | -3.51 |
HEALTHX Company Updates
FY 2026FY 2026
Investor Presentation
Jun 10PDF
Jun 1PDF
Feb 6PDF
+3 more
HEALTHX Stock Peers
HEALTHX Past Performance & Peer Comparison
HEALTHX Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Health X Platform Ltd | 825.46 | 1.13 | — |
| Inventurus Knowledge Solutions Ltd | 43.66 | 17.60 | — |
| Poly Medicure Limited | 53.76 | 6.26 | 0.20% |
| Fischer Medical Ventures Ltd | 79.46 | 7.30 | 1.29% |
HEALTHX Stock Price Comparison
Compare HEALTHX with any stock or ETFCompare HEALTHX with any stock or ETF
HEALTHX
HEALTHX Holdings
HEALTHX Shareholdings
HEALTHX Promoter Holdings Trend
HEALTHX Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
HEALTHX Institutional Holdings Trend
HEALTHX Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
HEALTHX Shareholding Pattern
HEALTHX Shareholding Pattern
HEALTHX Shareholding History
HEALTHX Shareholding History
Foreign Institutions
Mutual Funds Invested in HEALTHX
Mutual Funds Invested in HEALTHX
No mutual funds holding trends are available
Top 1 Mutual Funds holding Health X Platform Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0003% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 123/130 (-3) |
Compare 3-month MF holding change on Screener
smallcases containing HEALTHX stock
smallcases containing HEALTHX stock
Looks like this stock is not in any smallcase yet.
HEALTHX Events
HEALTHX Events
HEALTHX Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HEALTHX has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
HEALTHX Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HEALTHX has not given any dividends in last 5 years
HEALTHX Upcoming Dividends
HEALTHX Upcoming Dividends
No upcoming dividends are available
HEALTHX Past Dividends
HEALTHX Past Dividends
Cash Dividend
Ex DateEx DateJul 23, 2012
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 23, 2012
Cash Dividend
Ex DateEx DateJul 25, 2011
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 25, 2011
HEALTHX Stock News & Opinions
HEALTHX Stock News & Opinions
Articles & Videos
Earnings
Earnings
Health X Platform reports consolidated net loss of Rs 11.17 crore in the March 2026 quarterNet loss of Health X Platform reported to Rs 11.17 crore in the quarter ended March 2026 as against net profit of Rs 13.67 crore during the previous quarter ended March 2025. Sales rose 30.77% to Rs 373.78 crore in the quarter ended March 2026 as against Rs 285.84 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 1.18 crore in the year ended March 2026 as against net loss of Rs 91.17 crore during the previous year ended March 2025. Sales rose 18.75% to Rs 1319.27 crore in the year ended March 2026 as against Rs 1110.95 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales373.78285.84 31 1319.271110.95 19 OPM %-6.74-8.81 --3.95-5.04 - PBDT-11.92-3.58 -233 5.383.60 49 PBT-13.87-4.91 -182 -1.23-2.23 45 NP-11.1713.67 PL 1.18-91.17 LP Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Health X Platform to discuss resultsHealth X Platform will hold a meeting of the Board of Directors of the Company on 30 May 2026.
2 months agoCapital Market - Live
Earnings
Earnings
Sastasundar Ventures reports consolidated net profit of Rs 1.13 crore in the December 2025 quarterNet profit of Sastasundar Ventures reported to Rs 1.13 crore in the quarter ended December 2025 as against net loss of Rs 26.94 crore during the previous quarter ended December 2024. Sales rose 22.91% to Rs 345.74 crore in the quarter ended December 2025 as against Rs 281.29 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales345.74281.29 23 OPM %-3.00-8.43 - PBDT3.09-35.58 LP PBT0.92-37.01 LP NP1.13-26.94 LP Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Sastasundar Ventures announces board meeting dateSastasundar Ventures will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Earnings
Sastasundar Ventures reports consolidated net loss of Rs 12.69 crore in the September 2025 quarterNet Loss of Sastasundar Ventures reported to Rs 12.69 crore in the quarter ended September 2025 as against net loss of Rs 109.41 crore during the previous quarter ended September 2024. Sales rose 10.16% to Rs 301.32 crore in the quarter ended September 2025 as against Rs 273.53 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales301.32273.53 10 OPM %-7.50-1.73 - PBDT-17.1417.51 PL PBT-18.4716.05 PL NP-12.69-109.41 88 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Sastasundar Ventures to conduct board meetingSastasundar Ventures will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Sastasundar Ventures to convene AGMSastasundar Ventures announced that the 36th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Earnings
Earnings
Sastasundar Ventures consolidated net profit declines 23.24% in the June 2025 quarterNet profit of Sastasundar Ventures declined 23.24% to Rs 23.91 crore in the quarter ended June 2025 as against Rs 31.15 crore during the previous quarter ended June 2024. Sales rose 10.41% to Rs 298.43 crore in the quarter ended June 2025 as against Rs 270.29 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales298.43270.29 10 OPM %2.03-0.89 - PBDT31.3525.25 24 PBT30.1923.64 28 NP23.9131.15 -23 Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Corporate
Sastasundar Ventures to hold board meetingSastasundar Ventures will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Earnings
Earnings
Sastasundar Ventures consolidated net profit declines 16.85% in the March 2025 quarterNet profit of Sastasundar Ventures declined 16.85% to Rs 13.67 crore in the quarter ended March 2025 as against Rs 16.44 crore during the previous quarter ended March 2024. Sales declined 6.79% to Rs 285.84 crore in the quarter ended March 2025 as against Rs 306.67 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 91.17 crore in the year ended March 2025 as against net profit of Rs 8.88 crore during the previous year ended March 2024. Sales declined 19.25% to Rs 1110.95 crore in the year ended March 2025 as against Rs 1375.71 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales285.84306.67 -7 1110.951375.71 -19 OPM %-8.81-3.47 --5.040.39 - PBDT-3.587.54 PL 3.6064.82 -94 PBT-4.915.01 PL -2.2355.68 PL NP13.6716.44 -17 -91.178.88 PL Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 20.09%, vs industry avg of 24.41%
Over the last 5 years, market share decreased from 19.28% to 13.14%